nodes	percent_of_prediction	percent_of_DWPC	metapath
Irinotecan—Topoisomerase Inhibitors—Mitoxantrone—multiple sclerosis	0.574	1	CiPCiCtD
Irinotecan—BCHE—multiple sclerosis	0.114	0.709	CbGaD
Irinotecan—ALB—multiple sclerosis	0.0469	0.291	CbGaD
Irinotecan—ABCC1—Mitoxantrone—multiple sclerosis	0.0181	0.101	CbGbCtD
Irinotecan—BCHE—Triamcinolone—multiple sclerosis	0.0179	0.1	CbGbCtD
Irinotecan—ABCG2—Cladribine—multiple sclerosis	0.0166	0.093	CbGbCtD
Irinotecan—ABCG2—Mitoxantrone—multiple sclerosis	0.0121	0.0679	CbGbCtD
Irinotecan—ABCC1—Methotrexate—multiple sclerosis	0.00754	0.0423	CbGbCtD
Irinotecan—ABCC2—Dexamethasone—multiple sclerosis	0.00694	0.0389	CbGbCtD
Irinotecan—ALB—Prednisone—multiple sclerosis	0.00693	0.0389	CbGbCtD
Irinotecan—SLCO1B1—Methotrexate—multiple sclerosis	0.00635	0.0356	CbGbCtD
Irinotecan—ABCG2—Dexamethasone—multiple sclerosis	0.00628	0.0352	CbGbCtD
Irinotecan—ABCB1—Methylprednisolone—multiple sclerosis	0.00598	0.0335	CbGbCtD
Irinotecan—ABCC2—Methotrexate—multiple sclerosis	0.00558	0.0313	CbGbCtD
Irinotecan—CYP3A4—Fingolimod—multiple sclerosis	0.00556	0.0312	CbGbCtD
Irinotecan—ABCG2—Methotrexate—multiple sclerosis	0.00504	0.0283	CbGbCtD
Irinotecan—CYP3A7—Dexamethasone—multiple sclerosis	0.00464	0.026	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.00464	0.026	CbGbCtD
Irinotecan—CYP2B6—Dexamethasone—multiple sclerosis	0.00441	0.0247	CbGbCtD
Irinotecan—ABCB1—Mitoxantrone—multiple sclerosis	0.00437	0.0245	CbGbCtD
Irinotecan—ABCB1—Betamethasone—multiple sclerosis	0.00389	0.0218	CbGbCtD
Irinotecan—ABCB1—Prednisolone—multiple sclerosis	0.00384	0.0215	CbGbCtD
Irinotecan—ABCB1—Prednisone—multiple sclerosis	0.00363	0.0203	CbGbCtD
Irinotecan—CYP3A4—Methylprednisolone—multiple sclerosis	0.00359	0.0201	CbGbCtD
Irinotecan—CYP3A5—Dexamethasone—multiple sclerosis	0.00348	0.0195	CbGbCtD
Irinotecan—ALB—Methotrexate—multiple sclerosis	0.00348	0.0195	CbGbCtD
Irinotecan—CYP3A4—Triamcinolone—multiple sclerosis	0.00272	0.0152	CbGbCtD
Irinotecan—CYP3A4—Mitoxantrone—multiple sclerosis	0.00262	0.0147	CbGbCtD
Irinotecan—CYP3A4—Betamethasone—multiple sclerosis	0.00233	0.0131	CbGbCtD
Irinotecan—CYP3A4—Prednisolone—multiple sclerosis	0.0023	0.0129	CbGbCtD
Irinotecan—ABCB1—Dexamethasone—multiple sclerosis	0.00226	0.0127	CbGbCtD
Irinotecan—CYP3A4—Prednisone—multiple sclerosis	0.00217	0.0122	CbGbCtD
Irinotecan—ABCB1—Methotrexate—multiple sclerosis	0.00182	0.0102	CbGbCtD
Irinotecan—CYP3A4—Dexamethasone—multiple sclerosis	0.00136	0.0076	CbGbCtD
Irinotecan—TOP1MT—nervous system—multiple sclerosis	0.000382	0.0479	CbGeAlD
Irinotecan—TOP1—retina—multiple sclerosis	0.000371	0.0465	CbGeAlD
Irinotecan—TOP1MT—central nervous system—multiple sclerosis	0.000367	0.0461	CbGeAlD
Irinotecan—TOP1MT—cerebellum—multiple sclerosis	0.000359	0.045	CbGeAlD
Irinotecan—CES2—retina—multiple sclerosis	0.000336	0.0422	CbGeAlD
Irinotecan—TOP1MT—brain—multiple sclerosis	0.000292	0.0366	CbGeAlD
Irinotecan—TOP1—medulla oblongata—multiple sclerosis	0.000268	0.0336	CbGeAlD
Irinotecan—TOP1—midbrain—multiple sclerosis	0.000245	0.0307	CbGeAlD
Irinotecan—CES2—medulla oblongata—multiple sclerosis	0.000243	0.0305	CbGeAlD
Irinotecan—TOP1—spinal cord—multiple sclerosis	0.000239	0.03	CbGeAlD
Irinotecan—CES2—midbrain—multiple sclerosis	0.000222	0.0279	CbGeAlD
Irinotecan—CES2—spinal cord—multiple sclerosis	0.000217	0.0272	CbGeAlD
Irinotecan—ACHE—medulla oblongata—multiple sclerosis	0.0002	0.0251	CbGeAlD
Irinotecan—TOP1—cerebellum—multiple sclerosis	0.000189	0.0238	CbGeAlD
Irinotecan—ACHE—midbrain—multiple sclerosis	0.000183	0.0229	CbGeAlD
Irinotecan—CES2—nervous system—multiple sclerosis	0.000183	0.0229	CbGeAlD
Irinotecan—ACHE—spinal cord—multiple sclerosis	0.000178	0.0224	CbGeAlD
Irinotecan—CES2—central nervous system—multiple sclerosis	0.000176	0.022	CbGeAlD
Irinotecan—CES2—cerebellum—multiple sclerosis	0.000172	0.0215	CbGeAlD
Irinotecan—TOP1—brain—multiple sclerosis	0.000154	0.0193	CbGeAlD
Irinotecan—CES1—nervous system—multiple sclerosis	0.00015	0.0189	CbGeAlD
Irinotecan—CES1—central nervous system—multiple sclerosis	0.000145	0.0182	CbGeAlD
Irinotecan—ACHE—cerebellum—multiple sclerosis	0.000142	0.0177	CbGeAlD
Irinotecan—BCHE—brainstem—multiple sclerosis	0.000141	0.0177	CbGeAlD
Irinotecan—CES2—brain—multiple sclerosis	0.00014	0.0175	CbGeAlD
Irinotecan—ACHE—brain—multiple sclerosis	0.000115	0.0144	CbGeAlD
Irinotecan—CES1—brain—multiple sclerosis	0.000115	0.0144	CbGeAlD
Irinotecan—SLC22A3—nervous system—multiple sclerosis	0.000104	0.0131	CbGeAlD
Irinotecan—SLC22A3—central nervous system—multiple sclerosis	0.0001	0.0126	CbGeAlD
Irinotecan—BCHE—medulla oblongata—multiple sclerosis	9.84e-05	0.0123	CbGeAlD
Irinotecan—ABCG2—medulla oblongata—multiple sclerosis	9.51e-05	0.0119	CbGeAlD
Irinotecan—BCHE—midbrain—multiple sclerosis	8.99e-05	0.0113	CbGeAlD
Irinotecan—BCHE—spinal cord—multiple sclerosis	8.77e-05	0.011	CbGeAlD
Irinotecan—ABCG2—midbrain—multiple sclerosis	8.69e-05	0.0109	CbGeAlD
Irinotecan—ABCG2—spinal cord—multiple sclerosis	8.48e-05	0.0106	CbGeAlD
Irinotecan—ABCC1—cerebellum—multiple sclerosis	8.12e-05	0.0102	CbGeAlD
Irinotecan—ALB—brain—multiple sclerosis	7.99e-05	0.01	CbGeAlD
Irinotecan—SLC22A3—brain—multiple sclerosis	7.98e-05	0.01	CbGeAlD
Irinotecan—BCHE—nervous system—multiple sclerosis	7.39e-05	0.00927	CbGeAlD
Irinotecan—BCHE—central nervous system—multiple sclerosis	7.12e-05	0.00892	CbGeAlD
Irinotecan—BCHE—cerebellum—multiple sclerosis	6.96e-05	0.00872	CbGeAlD
Irinotecan—ABCG2—cerebellum—multiple sclerosis	6.72e-05	0.00843	CbGeAlD
Irinotecan—ABCC1—brain—multiple sclerosis	6.6e-05	0.00827	CbGeAlD
Irinotecan—CYP2B6—nervous system—multiple sclerosis	6.59e-05	0.00826	CbGeAlD
Irinotecan—ABCB1—retina—multiple sclerosis	6.49e-05	0.00813	CbGeAlD
Irinotecan—CYP2B6—central nervous system—multiple sclerosis	6.34e-05	0.00796	CbGeAlD
Irinotecan—BCHE—brain—multiple sclerosis	5.65e-05	0.00708	CbGeAlD
Irinotecan—ABCG2—brain—multiple sclerosis	5.46e-05	0.00685	CbGeAlD
Irinotecan—CYP2B6—brain—multiple sclerosis	5.04e-05	0.00632	CbGeAlD
Irinotecan—CYP3A4—nervous system—multiple sclerosis	4.98e-05	0.00624	CbGeAlD
Irinotecan—Vertigo—Triamcinolone—multiple sclerosis	4.8e-05	0.000897	CcSEcCtD
Irinotecan—Syncope—Triamcinolone—multiple sclerosis	4.8e-05	0.000895	CcSEcCtD
Irinotecan—Vertigo—Methylprednisolone—multiple sclerosis	4.79e-05	0.000895	CcSEcCtD
Irinotecan—CYP3A4—central nervous system—multiple sclerosis	4.79e-05	0.00601	CbGeAlD
Irinotecan—Syncope—Methylprednisolone—multiple sclerosis	4.78e-05	0.000893	CcSEcCtD
Irinotecan—Connective tissue disorder—Prednisone—multiple sclerosis	4.77e-05	0.00089	CcSEcCtD
Irinotecan—Feeling abnormal—Mitoxantrone—multiple sclerosis	4.77e-05	0.00089	CcSEcCtD
Irinotecan—Oedema—Prednisolone—multiple sclerosis	4.75e-05	0.000886	CcSEcCtD
Irinotecan—Anaphylactic shock—Prednisolone—multiple sclerosis	4.75e-05	0.000886	CcSEcCtD
Irinotecan—Neutropenia—Methotrexate—multiple sclerosis	4.74e-05	0.000885	CcSEcCtD
Irinotecan—Dizziness—Azathioprine—multiple sclerosis	4.73e-05	0.000883	CcSEcCtD
Irinotecan—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	4.73e-05	0.000883	CcSEcCtD
Irinotecan—Upper respiratory tract infection—Methotrexate—multiple sclerosis	4.71e-05	0.000879	CcSEcCtD
Irinotecan—Loss of consciousness—Triamcinolone—multiple sclerosis	4.7e-05	0.000877	CcSEcCtD
Irinotecan—Loss of consciousness—Methylprednisolone—multiple sclerosis	4.69e-05	0.000875	CcSEcCtD
Irinotecan—ABCB1—medulla oblongata—multiple sclerosis	4.69e-05	0.00588	CbGeAlD
Irinotecan—Shock—Prednisolone—multiple sclerosis	4.67e-05	0.000872	CcSEcCtD
Irinotecan—Cough—Triamcinolone—multiple sclerosis	4.67e-05	0.000871	CcSEcCtD
Irinotecan—Hypertension—Triamcinolone—multiple sclerosis	4.62e-05	0.000862	CcSEcCtD
Irinotecan—Hypertension—Methylprednisolone—multiple sclerosis	4.61e-05	0.00086	CcSEcCtD
Irinotecan—Hyperhidrosis—Prednisolone—multiple sclerosis	4.59e-05	0.000856	CcSEcCtD
Irinotecan—Body temperature increased—Mitoxantrone—multiple sclerosis	4.57e-05	0.000854	CcSEcCtD
Irinotecan—Abdominal pain—Mitoxantrone—multiple sclerosis	4.57e-05	0.000854	CcSEcCtD
Irinotecan—Vomiting—Azathioprine—multiple sclerosis	4.55e-05	0.000849	CcSEcCtD
Irinotecan—Pneumonia—Methotrexate—multiple sclerosis	4.54e-05	0.000848	CcSEcCtD
Irinotecan—Rash—Azathioprine—multiple sclerosis	4.51e-05	0.000842	CcSEcCtD
Irinotecan—Dermatitis—Azathioprine—multiple sclerosis	4.51e-05	0.000841	CcSEcCtD
Irinotecan—Flushing—Prednisone—multiple sclerosis	4.5e-05	0.000841	CcSEcCtD
Irinotecan—Ill-defined disorder—Dexamethasone—multiple sclerosis	4.5e-05	0.00084	CcSEcCtD
Irinotecan—Ill-defined disorder—Betamethasone—multiple sclerosis	4.5e-05	0.00084	CcSEcCtD
Irinotecan—Discomfort—Triamcinolone—multiple sclerosis	4.5e-05	0.00084	CcSEcCtD
Irinotecan—Discomfort—Methylprednisolone—multiple sclerosis	4.49e-05	0.000838	CcSEcCtD
Irinotecan—Headache—Azathioprine—multiple sclerosis	4.48e-05	0.000837	CcSEcCtD
Irinotecan—Renal failure—Methotrexate—multiple sclerosis	4.44e-05	0.000829	CcSEcCtD
Irinotecan—Stomatitis—Methotrexate—multiple sclerosis	4.4e-05	0.000822	CcSEcCtD
Irinotecan—Angiopathy—Prednisone—multiple sclerosis	4.4e-05	0.000822	CcSEcCtD
Irinotecan—Confusional state—Methylprednisolone—multiple sclerosis	4.39e-05	0.00082	CcSEcCtD
Irinotecan—Immune system disorder—Prednisone—multiple sclerosis	4.38e-05	0.000818	CcSEcCtD
Irinotecan—Malaise—Dexamethasone—multiple sclerosis	4.38e-05	0.000817	CcSEcCtD
Irinotecan—Malaise—Betamethasone—multiple sclerosis	4.38e-05	0.000817	CcSEcCtD
Irinotecan—Anaphylactic shock—Triamcinolone—multiple sclerosis	4.36e-05	0.000815	CcSEcCtD
Irinotecan—Oedema—Triamcinolone—multiple sclerosis	4.36e-05	0.000815	CcSEcCtD
Irinotecan—Vertigo—Dexamethasone—multiple sclerosis	4.36e-05	0.000814	CcSEcCtD
Irinotecan—Vertigo—Betamethasone—multiple sclerosis	4.36e-05	0.000814	CcSEcCtD
Irinotecan—Anaphylactic shock—Methylprednisolone—multiple sclerosis	4.35e-05	0.000813	CcSEcCtD
Irinotecan—Syncope—Dexamethasone—multiple sclerosis	4.35e-05	0.000812	CcSEcCtD
Irinotecan—Syncope—Betamethasone—multiple sclerosis	4.35e-05	0.000812	CcSEcCtD
Irinotecan—Arrhythmia—Prednisone—multiple sclerosis	4.34e-05	0.000809	CcSEcCtD
Irinotecan—Infection—Triamcinolone—multiple sclerosis	4.34e-05	0.000809	CcSEcCtD
Irinotecan—Sweating—Methotrexate—multiple sclerosis	4.33e-05	0.000809	CcSEcCtD
Irinotecan—Infection—Methylprednisolone—multiple sclerosis	4.33e-05	0.000808	CcSEcCtD
Irinotecan—Shock—Triamcinolone—multiple sclerosis	4.29e-05	0.000802	CcSEcCtD
Irinotecan—Insomnia—Prednisolone—multiple sclerosis	4.29e-05	0.000801	CcSEcCtD
Irinotecan—Alopecia—Prednisone—multiple sclerosis	4.29e-05	0.000801	CcSEcCtD
Irinotecan—ABCB1—midbrain—multiple sclerosis	4.28e-05	0.00537	CbGeAlD
Irinotecan—Shock—Methylprednisolone—multiple sclerosis	4.28e-05	0.0008	CcSEcCtD
Irinotecan—Nervous system disorder—Methylprednisolone—multiple sclerosis	4.27e-05	0.000797	CcSEcCtD
Irinotecan—Loss of consciousness—Dexamethasone—multiple sclerosis	4.26e-05	0.000796	CcSEcCtD
Irinotecan—Loss of consciousness—Betamethasone—multiple sclerosis	4.26e-05	0.000796	CcSEcCtD
Irinotecan—Hypersensitivity—Mitoxantrone—multiple sclerosis	4.26e-05	0.000796	CcSEcCtD
Irinotecan—Paraesthesia—Prednisolone—multiple sclerosis	4.26e-05	0.000795	CcSEcCtD
Irinotecan—Nausea—Azathioprine—multiple sclerosis	4.25e-05	0.000793	CcSEcCtD
Irinotecan—Hyperhidrosis—Triamcinolone—multiple sclerosis	4.22e-05	0.000788	CcSEcCtD
Irinotecan—Hyperhidrosis—Methylprednisolone—multiple sclerosis	4.21e-05	0.000786	CcSEcCtD
Irinotecan—Hypertension—Dexamethasone—multiple sclerosis	4.19e-05	0.000782	CcSEcCtD
Irinotecan—Hypertension—Betamethasone—multiple sclerosis	4.19e-05	0.000782	CcSEcCtD
Irinotecan—ABCB1—spinal cord—multiple sclerosis	4.18e-05	0.00524	CbGeAlD
Irinotecan—Asthenia—Mitoxantrone—multiple sclerosis	4.15e-05	0.000775	CcSEcCtD
Irinotecan—Discomfort—Betamethasone—multiple sclerosis	4.08e-05	0.000762	CcSEcCtD
Irinotecan—Discomfort—Dexamethasone—multiple sclerosis	4.08e-05	0.000762	CcSEcCtD
Irinotecan—Haemoglobin—Methotrexate—multiple sclerosis	4.08e-05	0.000761	CcSEcCtD
Irinotecan—Hypotension—Methylprednisolone—multiple sclerosis	4.07e-05	0.00076	CcSEcCtD
Irinotecan—Pain—Prednisolone—multiple sclerosis	4.06e-05	0.000758	CcSEcCtD
Irinotecan—Haemorrhage—Methotrexate—multiple sclerosis	4.06e-05	0.000757	CcSEcCtD
Irinotecan—Anaphylactic shock—Betamethasone—multiple sclerosis	3.96e-05	0.000739	CcSEcCtD
Irinotecan—Oedema—Betamethasone—multiple sclerosis	3.96e-05	0.000739	CcSEcCtD
Irinotecan—Oedema—Dexamethasone—multiple sclerosis	3.96e-05	0.000739	CcSEcCtD
Irinotecan—Anaphylactic shock—Dexamethasone—multiple sclerosis	3.96e-05	0.000739	CcSEcCtD
Irinotecan—Diarrhoea—Mitoxantrone—multiple sclerosis	3.96e-05	0.000739	CcSEcCtD
Irinotecan—Insomnia—Triamcinolone—multiple sclerosis	3.95e-05	0.000737	CcSEcCtD
Irinotecan—Insomnia—Methylprednisolone—multiple sclerosis	3.94e-05	0.000735	CcSEcCtD
Irinotecan—Infection—Betamethasone—multiple sclerosis	3.93e-05	0.000734	CcSEcCtD
Irinotecan—Infection—Dexamethasone—multiple sclerosis	3.93e-05	0.000734	CcSEcCtD
Irinotecan—Ill-defined disorder—Prednisone—multiple sclerosis	3.92e-05	0.000732	CcSEcCtD
Irinotecan—Paraesthesia—Triamcinolone—multiple sclerosis	3.92e-05	0.000732	CcSEcCtD
Irinotecan—Feeling abnormal—Prednisolone—multiple sclerosis	3.91e-05	0.00073	CcSEcCtD
Irinotecan—Paraesthesia—Methylprednisolone—multiple sclerosis	3.91e-05	0.00073	CcSEcCtD
Irinotecan—Visual impairment—Methotrexate—multiple sclerosis	3.91e-05	0.00073	CcSEcCtD
Irinotecan—Anaemia—Prednisone—multiple sclerosis	3.91e-05	0.000729	CcSEcCtD
Irinotecan—Shock—Dexamethasone—multiple sclerosis	3.9e-05	0.000727	CcSEcCtD
Irinotecan—Shock—Betamethasone—multiple sclerosis	3.9e-05	0.000727	CcSEcCtD
Irinotecan—Dyspnoea—Triamcinolone—multiple sclerosis	3.89e-05	0.000726	CcSEcCtD
Irinotecan—Nervous system disorder—Dexamethasone—multiple sclerosis	3.88e-05	0.000725	CcSEcCtD
Irinotecan—Nervous system disorder—Betamethasone—multiple sclerosis	3.88e-05	0.000725	CcSEcCtD
Irinotecan—Thrombocytopenia—Dexamethasone—multiple sclerosis	3.88e-05	0.000724	CcSEcCtD
Irinotecan—Thrombocytopenia—Betamethasone—multiple sclerosis	3.88e-05	0.000724	CcSEcCtD
Irinotecan—Dyspepsia—Triamcinolone—multiple sclerosis	3.84e-05	0.000717	CcSEcCtD
Irinotecan—Dyspepsia—Methylprednisolone—multiple sclerosis	3.83e-05	0.000716	CcSEcCtD
Irinotecan—Hyperhidrosis—Dexamethasone—multiple sclerosis	3.83e-05	0.000715	CcSEcCtD
Irinotecan—Hyperhidrosis—Betamethasone—multiple sclerosis	3.83e-05	0.000715	CcSEcCtD
Irinotecan—Malaise—Prednisone—multiple sclerosis	3.81e-05	0.000711	CcSEcCtD
Irinotecan—Vertigo—Prednisone—multiple sclerosis	3.8e-05	0.000709	CcSEcCtD
Irinotecan—Syncope—Prednisone—multiple sclerosis	3.79e-05	0.000707	CcSEcCtD
Irinotecan—Anorexia—Dexamethasone—multiple sclerosis	3.77e-05	0.000705	CcSEcCtD
Irinotecan—Anorexia—Betamethasone—multiple sclerosis	3.77e-05	0.000705	CcSEcCtD
Irinotecan—Cardiac disorder—Methotrexate—multiple sclerosis	3.76e-05	0.000703	CcSEcCtD
Irinotecan—Fatigue—Triamcinolone—multiple sclerosis	3.76e-05	0.000702	CcSEcCtD
Irinotecan—Fatigue—Methylprednisolone—multiple sclerosis	3.75e-05	0.000701	CcSEcCtD
Irinotecan—Pain—Triamcinolone—multiple sclerosis	3.73e-05	0.000697	CcSEcCtD
Irinotecan—Loss of consciousness—Prednisone—multiple sclerosis	3.71e-05	0.000693	CcSEcCtD
Irinotecan—Hypotension—Dexamethasone—multiple sclerosis	3.7e-05	0.000691	CcSEcCtD
Irinotecan—Hypotension—Betamethasone—multiple sclerosis	3.7e-05	0.000691	CcSEcCtD
Irinotecan—Angiopathy—Methotrexate—multiple sclerosis	3.68e-05	0.000687	CcSEcCtD
Irinotecan—Vomiting—Mitoxantrone—multiple sclerosis	3.68e-05	0.000687	CcSEcCtD
Irinotecan—Immune system disorder—Methotrexate—multiple sclerosis	3.66e-05	0.000684	CcSEcCtD
Irinotecan—Mediastinal disorder—Methotrexate—multiple sclerosis	3.66e-05	0.000682	CcSEcCtD
Irinotecan—Hypertension—Prednisone—multiple sclerosis	3.65e-05	0.000681	CcSEcCtD
Irinotecan—Rash—Mitoxantrone—multiple sclerosis	3.65e-05	0.000681	CcSEcCtD
Irinotecan—Dermatitis—Mitoxantrone—multiple sclerosis	3.64e-05	0.00068	CcSEcCtD
Irinotecan—Chills—Methotrexate—multiple sclerosis	3.64e-05	0.000679	CcSEcCtD
Irinotecan—Headache—Mitoxantrone—multiple sclerosis	3.62e-05	0.000676	CcSEcCtD
Irinotecan—Feeling abnormal—Triamcinolone—multiple sclerosis	3.6e-05	0.000671	CcSEcCtD
Irinotecan—Feeling abnormal—Methylprednisolone—multiple sclerosis	3.59e-05	0.00067	CcSEcCtD
Irinotecan—Alopecia—Methotrexate—multiple sclerosis	3.58e-05	0.000669	CcSEcCtD
Irinotecan—Insomnia—Dexamethasone—multiple sclerosis	3.58e-05	0.000669	CcSEcCtD
Irinotecan—Insomnia—Betamethasone—multiple sclerosis	3.58e-05	0.000669	CcSEcCtD
Irinotecan—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	3.56e-05	0.000665	CcSEcCtD
Irinotecan—Paraesthesia—Betamethasone—multiple sclerosis	3.56e-05	0.000664	CcSEcCtD
Irinotecan—Paraesthesia—Dexamethasone—multiple sclerosis	3.56e-05	0.000664	CcSEcCtD
Irinotecan—Discomfort—Prednisone—multiple sclerosis	3.55e-05	0.000663	CcSEcCtD
Irinotecan—ABCB1—nervous system—multiple sclerosis	3.52e-05	0.00442	CbGeAlD
Irinotecan—Hypersensitivity—Prednisolone—multiple sclerosis	3.5e-05	0.000653	CcSEcCtD
Irinotecan—Dyspepsia—Betamethasone—multiple sclerosis	3.49e-05	0.000651	CcSEcCtD
Irinotecan—Dyspepsia—Dexamethasone—multiple sclerosis	3.49e-05	0.000651	CcSEcCtD
Irinotecan—Body temperature increased—Triamcinolone—multiple sclerosis	3.45e-05	0.000644	CcSEcCtD
Irinotecan—Oedema—Prednisone—multiple sclerosis	3.45e-05	0.000644	CcSEcCtD
Irinotecan—Anaphylactic shock—Prednisone—multiple sclerosis	3.45e-05	0.000644	CcSEcCtD
Irinotecan—Abdominal pain—Methylprednisolone—multiple sclerosis	3.44e-05	0.000643	CcSEcCtD
Irinotecan—Decreased appetite—Dexamethasone—multiple sclerosis	3.44e-05	0.000643	CcSEcCtD
Irinotecan—Decreased appetite—Betamethasone—multiple sclerosis	3.44e-05	0.000643	CcSEcCtD
Irinotecan—Nausea—Mitoxantrone—multiple sclerosis	3.44e-05	0.000641	CcSEcCtD
Irinotecan—Infection—Prednisone—multiple sclerosis	3.43e-05	0.00064	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	3.42e-05	0.000638	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Betamethasone—multiple sclerosis	3.42e-05	0.000638	CcSEcCtD
Irinotecan—Back pain—Methotrexate—multiple sclerosis	3.42e-05	0.000638	CcSEcCtD
Irinotecan—Fatigue—Dexamethasone—multiple sclerosis	3.41e-05	0.000637	CcSEcCtD
Irinotecan—Fatigue—Betamethasone—multiple sclerosis	3.41e-05	0.000637	CcSEcCtD
Irinotecan—Shock—Prednisone—multiple sclerosis	3.39e-05	0.000633	CcSEcCtD
Irinotecan—ABCB1—central nervous system—multiple sclerosis	3.39e-05	0.00425	CbGeAlD
Irinotecan—Pain—Dexamethasone—multiple sclerosis	3.39e-05	0.000632	CcSEcCtD
Irinotecan—Pain—Betamethasone—multiple sclerosis	3.39e-05	0.000632	CcSEcCtD
Irinotecan—Nervous system disorder—Prednisone—multiple sclerosis	3.38e-05	0.000631	CcSEcCtD
Irinotecan—Hyperhidrosis—Prednisone—multiple sclerosis	3.33e-05	0.000622	CcSEcCtD
Irinotecan—ABCB1—cerebellum—multiple sclerosis	3.31e-05	0.00416	CbGeAlD
Irinotecan—Anorexia—Prednisone—multiple sclerosis	3.29e-05	0.000614	CcSEcCtD
Irinotecan—Ill-defined disorder—Methotrexate—multiple sclerosis	3.28e-05	0.000612	CcSEcCtD
Irinotecan—Anaemia—Methotrexate—multiple sclerosis	3.26e-05	0.000609	CcSEcCtD
Irinotecan—Feeling abnormal—Betamethasone—multiple sclerosis	3.26e-05	0.000609	CcSEcCtD
Irinotecan—Feeling abnormal—Dexamethasone—multiple sclerosis	3.26e-05	0.000609	CcSEcCtD
Irinotecan—Gastrointestinal pain—Betamethasone—multiple sclerosis	3.24e-05	0.000604	CcSEcCtD
Irinotecan—Gastrointestinal pain—Dexamethasone—multiple sclerosis	3.24e-05	0.000604	CcSEcCtD
Irinotecan—Hypersensitivity—Triamcinolone—multiple sclerosis	3.22e-05	0.0006	CcSEcCtD
Irinotecan—Hypersensitivity—Methylprednisolone—multiple sclerosis	3.21e-05	0.000599	CcSEcCtD
Irinotecan—Malaise—Methotrexate—multiple sclerosis	3.18e-05	0.000594	CcSEcCtD
Irinotecan—Vertigo—Methotrexate—multiple sclerosis	3.17e-05	0.000592	CcSEcCtD
Irinotecan—Leukopenia—Methotrexate—multiple sclerosis	3.16e-05	0.00059	CcSEcCtD
Irinotecan—Dizziness—Prednisolone—multiple sclerosis	3.14e-05	0.000586	CcSEcCtD
Irinotecan—Asthenia—Triamcinolone—multiple sclerosis	3.13e-05	0.000585	CcSEcCtD
Irinotecan—Body temperature increased—Betamethasone—multiple sclerosis	3.13e-05	0.000584	CcSEcCtD
Irinotecan—Abdominal pain—Betamethasone—multiple sclerosis	3.13e-05	0.000584	CcSEcCtD
Irinotecan—Abdominal pain—Dexamethasone—multiple sclerosis	3.13e-05	0.000584	CcSEcCtD
Irinotecan—Body temperature increased—Dexamethasone—multiple sclerosis	3.13e-05	0.000584	CcSEcCtD
Irinotecan—Asthenia—Methylprednisolone—multiple sclerosis	3.12e-05	0.000583	CcSEcCtD
Irinotecan—Insomnia—Prednisone—multiple sclerosis	3.12e-05	0.000582	CcSEcCtD
Irinotecan—Paraesthesia—Prednisone—multiple sclerosis	3.1e-05	0.000578	CcSEcCtD
Irinotecan—Cough—Methotrexate—multiple sclerosis	3.08e-05	0.000575	CcSEcCtD
Irinotecan—Dyspepsia—Prednisone—multiple sclerosis	3.04e-05	0.000567	CcSEcCtD
Irinotecan—Decreased appetite—Prednisone—multiple sclerosis	3e-05	0.00056	CcSEcCtD
Irinotecan—Rash—Prednisolone—multiple sclerosis	2.99e-05	0.000559	CcSEcCtD
Irinotecan—Dermatitis—Prednisolone—multiple sclerosis	2.99e-05	0.000558	CcSEcCtD
Irinotecan—Diarrhoea—Methylprednisolone—multiple sclerosis	2.98e-05	0.000556	CcSEcCtD
Irinotecan—Fatigue—Prednisone—multiple sclerosis	2.97e-05	0.000555	CcSEcCtD
Irinotecan—Headache—Prednisolone—multiple sclerosis	2.97e-05	0.000555	CcSEcCtD
Irinotecan—Discomfort—Methotrexate—multiple sclerosis	2.97e-05	0.000554	CcSEcCtD
Irinotecan—Constipation—Prednisone—multiple sclerosis	2.95e-05	0.00055	CcSEcCtD
Irinotecan—Confusional state—Methotrexate—multiple sclerosis	2.91e-05	0.000542	CcSEcCtD
Irinotecan—Dizziness—Triamcinolone—multiple sclerosis	2.89e-05	0.000539	CcSEcCtD
Irinotecan—Anaphylactic shock—Methotrexate—multiple sclerosis	2.88e-05	0.000538	CcSEcCtD
Irinotecan—Dizziness—Methylprednisolone—multiple sclerosis	2.88e-05	0.000538	CcSEcCtD
Irinotecan—Infection—Methotrexate—multiple sclerosis	2.86e-05	0.000534	CcSEcCtD
Irinotecan—Feeling abnormal—Prednisone—multiple sclerosis	2.84e-05	0.00053	CcSEcCtD
Irinotecan—Asthenia—Dexamethasone—multiple sclerosis	2.84e-05	0.00053	CcSEcCtD
Irinotecan—Asthenia—Betamethasone—multiple sclerosis	2.84e-05	0.00053	CcSEcCtD
Irinotecan—Nervous system disorder—Methotrexate—multiple sclerosis	2.83e-05	0.000528	CcSEcCtD
Irinotecan—Thrombocytopenia—Methotrexate—multiple sclerosis	2.82e-05	0.000527	CcSEcCtD
Irinotecan—Gastrointestinal pain—Prednisone—multiple sclerosis	2.82e-05	0.000526	CcSEcCtD
Irinotecan—Nausea—Prednisolone—multiple sclerosis	2.82e-05	0.000526	CcSEcCtD
Irinotecan—Hyperhidrosis—Methotrexate—multiple sclerosis	2.79e-05	0.00052	CcSEcCtD
Irinotecan—Vomiting—Triamcinolone—multiple sclerosis	2.77e-05	0.000518	CcSEcCtD
Irinotecan—Vomiting—Methylprednisolone—multiple sclerosis	2.77e-05	0.000517	CcSEcCtD
Irinotecan—Rash—Triamcinolone—multiple sclerosis	2.75e-05	0.000514	CcSEcCtD
Irinotecan—Dermatitis—Triamcinolone—multiple sclerosis	2.75e-05	0.000513	CcSEcCtD
Irinotecan—Anorexia—Methotrexate—multiple sclerosis	2.75e-05	0.000513	CcSEcCtD
Irinotecan—Rash—Methylprednisolone—multiple sclerosis	2.75e-05	0.000513	CcSEcCtD
Irinotecan—Dermatitis—Methylprednisolone—multiple sclerosis	2.74e-05	0.000512	CcSEcCtD
Irinotecan—Headache—Triamcinolone—multiple sclerosis	2.73e-05	0.00051	CcSEcCtD
Irinotecan—Headache—Methylprednisolone—multiple sclerosis	2.73e-05	0.000509	CcSEcCtD
Irinotecan—Abdominal pain—Prednisone—multiple sclerosis	2.73e-05	0.000509	CcSEcCtD
Irinotecan—Body temperature increased—Prednisone—multiple sclerosis	2.73e-05	0.000509	CcSEcCtD
Irinotecan—Diarrhoea—Dexamethasone—multiple sclerosis	2.71e-05	0.000506	CcSEcCtD
Irinotecan—Diarrhoea—Betamethasone—multiple sclerosis	2.71e-05	0.000506	CcSEcCtD
Irinotecan—Hypotension—Methotrexate—multiple sclerosis	2.69e-05	0.000503	CcSEcCtD
Irinotecan—ABCB1—brain—multiple sclerosis	2.69e-05	0.00338	CbGeAlD
Irinotecan—Dizziness—Betamethasone—multiple sclerosis	2.62e-05	0.000489	CcSEcCtD
Irinotecan—Dizziness—Dexamethasone—multiple sclerosis	2.62e-05	0.000489	CcSEcCtD
Irinotecan—Insomnia—Methotrexate—multiple sclerosis	2.61e-05	0.000487	CcSEcCtD
Irinotecan—Nausea—Triamcinolone—multiple sclerosis	2.59e-05	0.000484	CcSEcCtD
Irinotecan—Paraesthesia—Methotrexate—multiple sclerosis	2.59e-05	0.000483	CcSEcCtD
Irinotecan—Nausea—Methylprednisolone—multiple sclerosis	2.59e-05	0.000483	CcSEcCtD
Irinotecan—Dyspnoea—Methotrexate—multiple sclerosis	2.57e-05	0.00048	CcSEcCtD
Irinotecan—Somnolence—Methotrexate—multiple sclerosis	2.56e-05	0.000478	CcSEcCtD
Irinotecan—Hypersensitivity—Prednisone—multiple sclerosis	2.54e-05	0.000474	CcSEcCtD
Irinotecan—Dyspepsia—Methotrexate—multiple sclerosis	2.54e-05	0.000474	CcSEcCtD
Irinotecan—Vomiting—Betamethasone—multiple sclerosis	2.52e-05	0.00047	CcSEcCtD
Irinotecan—Vomiting—Dexamethasone—multiple sclerosis	2.52e-05	0.00047	CcSEcCtD
Irinotecan—Decreased appetite—Methotrexate—multiple sclerosis	2.51e-05	0.000468	CcSEcCtD
Irinotecan—Rash—Dexamethasone—multiple sclerosis	2.5e-05	0.000466	CcSEcCtD
Irinotecan—Rash—Betamethasone—multiple sclerosis	2.5e-05	0.000466	CcSEcCtD
Irinotecan—Dermatitis—Betamethasone—multiple sclerosis	2.49e-05	0.000466	CcSEcCtD
Irinotecan—Dermatitis—Dexamethasone—multiple sclerosis	2.49e-05	0.000466	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Methotrexate—multiple sclerosis	2.49e-05	0.000464	CcSEcCtD
Irinotecan—Fatigue—Methotrexate—multiple sclerosis	2.48e-05	0.000464	CcSEcCtD
Irinotecan—Headache—Dexamethasone—multiple sclerosis	2.48e-05	0.000463	CcSEcCtD
Irinotecan—Headache—Betamethasone—multiple sclerosis	2.48e-05	0.000463	CcSEcCtD
Irinotecan—Asthenia—Prednisone—multiple sclerosis	2.47e-05	0.000462	CcSEcCtD
Irinotecan—Pain—Methotrexate—multiple sclerosis	2.46e-05	0.00046	CcSEcCtD
Irinotecan—Feeling abnormal—Methotrexate—multiple sclerosis	2.37e-05	0.000443	CcSEcCtD
Irinotecan—Diarrhoea—Prednisone—multiple sclerosis	2.36e-05	0.00044	CcSEcCtD
Irinotecan—Gastrointestinal pain—Methotrexate—multiple sclerosis	2.36e-05	0.00044	CcSEcCtD
Irinotecan—Nausea—Betamethasone—multiple sclerosis	2.35e-05	0.000439	CcSEcCtD
Irinotecan—Nausea—Dexamethasone—multiple sclerosis	2.35e-05	0.000439	CcSEcCtD
Irinotecan—Dizziness—Prednisone—multiple sclerosis	2.28e-05	0.000426	CcSEcCtD
Irinotecan—Abdominal pain—Methotrexate—multiple sclerosis	2.28e-05	0.000425	CcSEcCtD
Irinotecan—Body temperature increased—Methotrexate—multiple sclerosis	2.28e-05	0.000425	CcSEcCtD
Irinotecan—Vomiting—Prednisone—multiple sclerosis	2.19e-05	0.000409	CcSEcCtD
Irinotecan—Rash—Prednisone—multiple sclerosis	2.17e-05	0.000406	CcSEcCtD
Irinotecan—Dermatitis—Prednisone—multiple sclerosis	2.17e-05	0.000406	CcSEcCtD
Irinotecan—Headache—Prednisone—multiple sclerosis	2.16e-05	0.000403	CcSEcCtD
Irinotecan—Hypersensitivity—Methotrexate—multiple sclerosis	2.12e-05	0.000396	CcSEcCtD
Irinotecan—Asthenia—Methotrexate—multiple sclerosis	2.07e-05	0.000386	CcSEcCtD
Irinotecan—Nausea—Prednisone—multiple sclerosis	2.05e-05	0.000382	CcSEcCtD
Irinotecan—Diarrhoea—Methotrexate—multiple sclerosis	1.97e-05	0.000368	CcSEcCtD
Irinotecan—Dizziness—Methotrexate—multiple sclerosis	1.91e-05	0.000356	CcSEcCtD
Irinotecan—Vomiting—Methotrexate—multiple sclerosis	1.83e-05	0.000342	CcSEcCtD
Irinotecan—Rash—Methotrexate—multiple sclerosis	1.82e-05	0.000339	CcSEcCtD
Irinotecan—Dermatitis—Methotrexate—multiple sclerosis	1.82e-05	0.000339	CcSEcCtD
Irinotecan—Headache—Methotrexate—multiple sclerosis	1.81e-05	0.000337	CcSEcCtD
Irinotecan—Nausea—Methotrexate—multiple sclerosis	1.71e-05	0.00032	CcSEcCtD
Irinotecan—BCHE—Metabolism—SRM—multiple sclerosis	1.7e-05	0.000666	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.69e-05	0.000662	CbGpPWpGaD
Irinotecan—UGT1A1—Biological oxidations—POMC—multiple sclerosis	1.67e-05	0.000656	CbGpPWpGaD
Irinotecan—UGT1A9—Biological oxidations—POMC—multiple sclerosis	1.67e-05	0.000656	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—SRM—multiple sclerosis	1.65e-05	0.000649	CbGpPWpGaD
Irinotecan—ALB—Selenium Micronutrient Network—ICAM1—multiple sclerosis	1.64e-05	0.000642	CbGpPWpGaD
Irinotecan—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	1.63e-05	0.000639	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.6e-05	0.000629	CbGpPWpGaD
Irinotecan—ALB—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	1.59e-05	0.000625	CbGpPWpGaD
Irinotecan—ALB—Folate Metabolism—IFNG—multiple sclerosis	1.57e-05	0.000615	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—GPC5—multiple sclerosis	1.56e-05	0.000611	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of proteins—RPL5—multiple sclerosis	1.55e-05	0.000607	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—SRM—multiple sclerosis	1.53e-05	0.000601	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of proteins—PABPC1—multiple sclerosis	1.53e-05	0.0006	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	1.53e-05	0.0006	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—SRM—multiple sclerosis	1.52e-05	0.000596	CbGpPWpGaD
Irinotecan—ABCC2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.51e-05	0.000592	CbGpPWpGaD
Irinotecan—ABCB1—Allograft Rejection—CD80—multiple sclerosis	1.5e-05	0.000591	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.49e-05	0.000587	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.49e-05	0.000587	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.49e-05	0.000585	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.48e-05	0.000583	CbGpPWpGaD
Irinotecan—SLC22A3—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.47e-05	0.000576	CbGpPWpGaD
Irinotecan—ALB—Selenium Micronutrient Network—CCL2—multiple sclerosis	1.46e-05	0.000575	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.42e-05	0.000556	CbGpPWpGaD
Irinotecan—CYP3A7—Biological oxidations—POMC—multiple sclerosis	1.41e-05	0.000552	CbGpPWpGaD
Irinotecan—ALB—Folate Metabolism—IL1B—multiple sclerosis	1.4e-05	0.000549	CbGpPWpGaD
Irinotecan—ALB—Folate Metabolism—IL2—multiple sclerosis	1.39e-05	0.000547	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of proteins—RPL5—multiple sclerosis	1.38e-05	0.000541	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—CYP27B1—multiple sclerosis	1.34e-05	0.000526	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—CYP24A1—multiple sclerosis	1.34e-05	0.000526	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	1.34e-05	0.000526	CbGpPWpGaD
Irinotecan—ABCC1—Disease—GPC5—multiple sclerosis	1.34e-05	0.000526	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—PLEK—multiple sclerosis	1.34e-05	0.000525	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.31e-05	0.000515	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.31e-05	0.000514	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	1.3e-05	0.000511	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—RRM1—multiple sclerosis	1.29e-05	0.000506	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—CYP27B1—multiple sclerosis	1.27e-05	0.000499	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—CYP24A1—multiple sclerosis	1.27e-05	0.000499	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—CYP24A1—multiple sclerosis	1.27e-05	0.000499	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—CYP27B1—multiple sclerosis	1.27e-05	0.000499	CbGpPWpGaD
Irinotecan—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	1.25e-05	0.000489	CbGpPWpGaD
Irinotecan—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	1.25e-05	0.000489	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.24e-05	0.000488	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—CYP27B1—multiple sclerosis	1.23e-05	0.000481	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—CYP24A1—multiple sclerosis	1.23e-05	0.000481	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—GPC5—multiple sclerosis	1.23e-05	0.000481	CbGpPWpGaD
Irinotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	1.21e-05	0.000475	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.2e-05	0.00047	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—CYP24A1—multiple sclerosis	1.2e-05	0.000469	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—CYP27B1—multiple sclerosis	1.2e-05	0.000469	CbGpPWpGaD
Irinotecan—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	1.19e-05	0.000467	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—CYP27B1—multiple sclerosis	1.16e-05	0.000457	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—CYP24A1—multiple sclerosis	1.16e-05	0.000457	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—GPC5—multiple sclerosis	1.16e-05	0.000456	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—GPC5—multiple sclerosis	1.16e-05	0.000456	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.16e-05	0.000455	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.14e-05	0.000447	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of proteins—BCHE—multiple sclerosis	1.13e-05	0.000444	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—SRM—multiple sclerosis	1.12e-05	0.000441	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—GPC5—multiple sclerosis	1.12e-05	0.00044	CbGpPWpGaD
Irinotecan—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	1.11e-05	0.000436	CbGpPWpGaD
Irinotecan—UGT1A1—NRF2 pathway—TGFB1—multiple sclerosis	1.1e-05	0.000432	CbGpPWpGaD
Irinotecan—UGT1A9—NRF2 pathway—TGFB1—multiple sclerosis	1.1e-05	0.000432	CbGpPWpGaD
Irinotecan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.1e-05	0.000431	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—SRM—multiple sclerosis	1.1e-05	0.000431	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—GPC5—multiple sclerosis	1.09e-05	0.000429	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—CYP27B1—multiple sclerosis	1.08e-05	0.000423	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—CYP24A1—multiple sclerosis	1.08e-05	0.000423	CbGpPWpGaD
Irinotecan—ABCC2—NRF2 pathway—TGFB1—multiple sclerosis	1.07e-05	0.000421	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	1.07e-05	0.00042	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	1.07e-05	0.00042	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—GPC5—multiple sclerosis	1.07e-05	0.000418	CbGpPWpGaD
Irinotecan—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	1.06e-05	0.000416	CbGpPWpGaD
Irinotecan—ABCB1—Allograft Rejection—IL2—multiple sclerosis	1.06e-05	0.000415	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	1.05e-05	0.00041	CbGpPWpGaD
Irinotecan—CYP2B6—Biological oxidations—POMC—multiple sclerosis	1.04e-05	0.000408	CbGpPWpGaD
Irinotecan—CYP3A5—Biological oxidations—POMC—multiple sclerosis	1.02e-05	0.000399	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—RRM1—multiple sclerosis	1.02e-05	0.000399	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.02e-05	0.000398	CbGpPWpGaD
Irinotecan—ALB—Folate Metabolism—TNF—multiple sclerosis	1.01e-05	0.000398	CbGpPWpGaD
Irinotecan—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	1.01e-05	0.000395	CbGpPWpGaD
Irinotecan—SLCO1B1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1e-05	0.000394	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—GPC5—multiple sclerosis	9.87e-06	0.000387	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—GPC5—multiple sclerosis	9.78e-06	0.000384	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—RRM1—multiple sclerosis	9.63e-06	0.000378	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—RRM1—multiple sclerosis	9.63e-06	0.000378	CbGpPWpGaD
Irinotecan—ALB—Metabolism—SRM—multiple sclerosis	9.45e-06	0.000371	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—SELE—multiple sclerosis	9.43e-06	0.00037	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	9.37e-06	0.000368	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	9.35e-06	0.000367	CbGpPWpGaD
Irinotecan—ALB—Platelet degranulation—TGFB1—multiple sclerosis	9.31e-06	0.000366	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—RRM1—multiple sclerosis	9.29e-06	0.000365	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	9.17e-06	0.00036	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	9.16e-06	0.000359	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—RRM1—multiple sclerosis	9.06e-06	0.000356	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	9.03e-06	0.000355	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	8.95e-06	0.000351	CbGpPWpGaD
Irinotecan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.9e-06	0.000349	CbGpPWpGaD
Irinotecan—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	8.87e-06	0.000348	CbGpPWpGaD
Irinotecan—ACHE—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	8.83e-06	0.000347	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—RRM1—multiple sclerosis	8.83e-06	0.000347	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	8.73e-06	0.000343	CbGpPWpGaD
Irinotecan—ABCC1—Disease—RPL5—multiple sclerosis	8.71e-06	0.000342	CbGpPWpGaD
Irinotecan—ABCC1—Disease—SLC11A1—multiple sclerosis	8.34e-06	0.000327	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—SRM—multiple sclerosis	8.28e-06	0.000325	CbGpPWpGaD
Irinotecan—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	8.24e-06	0.000324	CbGpPWpGaD
Irinotecan—ALB—Folate Metabolism—IL6—multiple sclerosis	8.19e-06	0.000321	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—RRM1—multiple sclerosis	8.18e-06	0.000321	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—RRM1—multiple sclerosis	8.1e-06	0.000318	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	8.1e-06	0.000318	CbGpPWpGaD
Irinotecan—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	8.06e-06	0.000316	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.02e-06	0.000315	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	7.91e-06	0.00031	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	7.91e-06	0.00031	CbGpPWpGaD
Irinotecan—BCHE—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	7.88e-06	0.000309	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.88e-06	0.000309	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	7.73e-06	0.000303	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	7.73e-06	0.000303	CbGpPWpGaD
Irinotecan—ABCB1—Allograft Rejection—TNF—multiple sclerosis	7.7e-06	0.000302	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.48e-06	0.000293	CbGpPWpGaD
Irinotecan—SLC22A3—Transmembrane transport of small molecules—ALB—multiple sclerosis	7.45e-06	0.000293	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—BCHE—multiple sclerosis	7.41e-06	0.000291	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GPC5—multiple sclerosis	7.23e-06	0.000284	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.21e-06	0.000283	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.09e-06	0.000278	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GPC5—multiple sclerosis	7.07e-06	0.000277	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.03e-06	0.000276	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.85e-06	0.000269	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—ITGA4—multiple sclerosis	6.82e-06	0.000268	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—MAPK1—multiple sclerosis	6.77e-06	0.000266	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.77e-06	0.000266	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—IFNB1—multiple sclerosis	6.77e-06	0.000266	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CD28—multiple sclerosis	6.66e-06	0.000261	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CYP24A1—multiple sclerosis	6.66e-06	0.000261	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CYP27B1—multiple sclerosis	6.66e-06	0.000261	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.51e-06	0.000255	CbGpPWpGaD
Irinotecan—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	6.5e-06	0.000255	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.42e-06	0.000252	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.19e-06	0.000243	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.17e-06	0.000242	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GPC5—multiple sclerosis	6.09e-06	0.000239	CbGpPWpGaD
Irinotecan—BCHE—Neuronal System—MAPK1—multiple sclerosis	6.04e-06	0.000237	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.04e-06	0.000237	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—RRM1—multiple sclerosis	5.99e-06	0.000235	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.88e-06	0.000231	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—RRM1—multiple sclerosis	5.86e-06	0.00023	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.85e-06	0.00023	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of proteins—POMC—multiple sclerosis	5.85e-06	0.00023	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—BCHE—multiple sclerosis	5.83e-06	0.000229	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CYP27B1—multiple sclerosis	5.83e-06	0.000229	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CYP24A1—multiple sclerosis	5.83e-06	0.000229	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of proteins—CCL2—multiple sclerosis	5.72e-06	0.000225	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.65e-06	0.000222	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—BCHE—multiple sclerosis	5.53e-06	0.000217	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—BCHE—multiple sclerosis	5.53e-06	0.000217	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.5e-06	0.000216	CbGpPWpGaD
Irinotecan—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.43e-06	0.000213	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.37e-06	0.000211	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.36e-06	0.000211	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—BCHE—multiple sclerosis	5.34e-06	0.000209	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GPC5—multiple sclerosis	5.33e-06	0.000209	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	5.3e-06	0.000208	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of proteins—POMC—multiple sclerosis	5.22e-06	0.000205	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of proteins—CCL2—multiple sclerosis	5.1e-06	0.0002	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.1e-06	0.0002	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SRM—multiple sclerosis	5.1e-06	0.0002	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—BCHE—multiple sclerosis	5.07e-06	0.000199	CbGpPWpGaD
Irinotecan—ALB—Metabolism—RRM1—multiple sclerosis	5.04e-06	0.000198	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CD86—multiple sclerosis	4.75e-06	0.000186	CbGpPWpGaD
Irinotecan—CYP3A4—Biological oxidations—POMC—multiple sclerosis	4.73e-06	0.000186	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.72e-06	0.000185	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—BCHE—multiple sclerosis	4.7e-06	0.000184	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—IL2RA—multiple sclerosis	4.66e-06	0.000183	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—BCHE—multiple sclerosis	4.65e-06	0.000183	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—APOE—multiple sclerosis	4.46e-06	0.000175	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—RRM1—multiple sclerosis	4.42e-06	0.000173	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CCR5—multiple sclerosis	4.21e-06	0.000165	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	4.13e-06	0.000162	CbGpPWpGaD
Irinotecan—ABCC1—Disease—HLA-A—multiple sclerosis	4.11e-06	0.000161	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	4.08e-06	0.00016	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	4.07e-06	0.00016	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	4.05e-06	0.000159	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	3.99e-06	0.000157	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.91e-06	0.000154	CbGpPWpGaD
Irinotecan—ABCC1—Disease—APOE—multiple sclerosis	3.83e-06	0.00015	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—POMC—multiple sclerosis	3.83e-06	0.00015	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	3.8e-06	0.000149	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	3.59e-06	0.000141	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	3.59e-06	0.000141	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—APOE—multiple sclerosis	3.51e-06	0.000138	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—ALB—multiple sclerosis	3.49e-06	0.000137	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CD80—multiple sclerosis	3.47e-06	0.000136	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—BCHE—multiple sclerosis	3.44e-06	0.000135	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—BCHE—multiple sclerosis	3.36e-06	0.000132	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.36e-06	0.000132	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—APOE—multiple sclerosis	3.33e-06	0.000131	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—APOE—multiple sclerosis	3.33e-06	0.000131	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GPC5—multiple sclerosis	3.29e-06	0.000129	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—APOE—multiple sclerosis	3.21e-06	0.000126	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—APOE—multiple sclerosis	3.13e-06	0.000123	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—APOE—multiple sclerosis	3.05e-06	0.00012	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—POMC—multiple sclerosis	3.01e-06	0.000118	CbGpPWpGaD
Irinotecan—ABCC1—Disease—TYK2—multiple sclerosis	2.93e-06	0.000115	CbGpPWpGaD
Irinotecan—ALB—Metabolism—BCHE—multiple sclerosis	2.9e-06	0.000114	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—POMC—multiple sclerosis	2.86e-06	0.000112	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—POMC—multiple sclerosis	2.86e-06	0.000112	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—APOE—multiple sclerosis	2.82e-06	0.000111	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—APOE—multiple sclerosis	2.8e-06	0.00011	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—POMC—multiple sclerosis	2.76e-06	0.000108	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—ALB—multiple sclerosis	2.75e-06	0.000108	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—IL2—multiple sclerosis	2.73e-06	0.000107	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.72e-06	0.000107	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—POMC—multiple sclerosis	2.69e-06	0.000106	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CD4—multiple sclerosis	2.65e-06	0.000104	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—POMC—multiple sclerosis	2.62e-06	0.000103	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—ALB—multiple sclerosis	2.61e-06	0.000102	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—ALB—multiple sclerosis	2.61e-06	0.000102	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.55e-06	0.0001	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—BCHE—multiple sclerosis	2.54e-06	9.96e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—ALB—multiple sclerosis	2.51e-06	9.87e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—ALB—multiple sclerosis	2.45e-06	9.62e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—POMC—multiple sclerosis	2.43e-06	9.53e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—POMC—multiple sclerosis	2.41e-06	9.44e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—ALB—multiple sclerosis	2.39e-06	9.38e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—ALB—multiple sclerosis	2.21e-06	8.68e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—ALB—multiple sclerosis	2.19e-06	8.61e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—TGFB1—multiple sclerosis	2.13e-06	8.36e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—MAPK1—multiple sclerosis	2.09e-06	8.2e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—APOE—multiple sclerosis	2.07e-06	8.13e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—STAT3—multiple sclerosis	2.05e-06	8.04e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—APOE—multiple sclerosis	2.02e-06	7.94e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MYC—multiple sclerosis	1.9e-06	7.47e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—TGFB1—multiple sclerosis	1.9e-06	7.45e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MAPK1—multiple sclerosis	1.86e-06	7.31e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—POMC—multiple sclerosis	1.78e-06	6.98e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—APOE—multiple sclerosis	1.74e-06	6.84e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—POMC—multiple sclerosis	1.74e-06	6.82e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ALB—multiple sclerosis	1.62e-06	6.37e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ALB—multiple sclerosis	1.59e-06	6.22e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.56e-06	6.14e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—APOE—multiple sclerosis	1.53e-06	5.99e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—POMC—multiple sclerosis	1.5e-06	5.88e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—IL6—multiple sclerosis	1.43e-06	5.62e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—POMC—multiple sclerosis	1.31e-06	5.15e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ALB—multiple sclerosis	1.2e-06	4.7e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—APOE—multiple sclerosis	9.41e-07	3.69e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—POMC—multiple sclerosis	8.08e-07	3.17e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ALB—multiple sclerosis	7.37e-07	2.89e-05	CbGpPWpGaD
